Issued Patents. If Licensee plans to abandon any issued patent or non-provisional patent application within the Licensed Patents in any country in the Territory, Licensee shall notify Sanofi in writing at least [***] in advance of the due date of any payment or other action that is required to maintain such Licensed Patent, and Sanofi shall have the right, in its sole discretion, to assume control and direction of the maintenance of such Licensed Patent at its sole cost and expense in such country. Upon receipt of written notice that Sanofi has elected to exercise its back-up rights under this Section 7.2.2(ii) with respect to such abandoned Licensed Patent in a specific country, the licenses under such Licensed Patent granted to Licensee in Section 2.2.1 shall terminate with respect to such Licensed Patents in such country.
Appears in 3 contracts
Sources: License Agreement (Sionna Therapeutics, Inc.), License Agreement (Sionna Therapeutics, Inc.), License Agreement (Sionna Therapeutics, Inc.)